Hormonal changes after menopause impact multiple sclerosis severity

A new study by UC San Francisco has found that menopause revs up the progression of multiple sclerosis (MS).

Could Francis Collins’s Prostate Cancer Story Deter Men From Active Surveillance?

Former NIH director Francis Collins, MD, PhD, one of America’s most prominent physicians and the leader of the ground-breaking Human Genome Project, has gone public

April 18, 2024

BlueRock, bit.bio partner to develop T cell based therapies

bit.bio’s opti-ox precision cell programming technology is used to control the expression of TF combinations within Treg cell therapies. Credit: Design_Cells / Shutterstock.com. BlueRock Therapeutics

August 4, 2023

Cerevance’s $47M raise; Parexel’s AI pact

Plus, news about Intra-Cellular: Cerevance adds $47 million to Series B: The neurological disease biotech’s series B-1 raise now sits at $98 million, with investments from Agent Capital,

April 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.